0
Upcoming Allied Market Research
2022
Digital Genome Market

Digital Genome Market

- Global Opportunity Analysis and Industry Forecast, 2022-2029

Report Code: A08199
Pages: NA
Nov 2022 | 1384 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Digital Genome Market

Request Now !

A genome refers an organism’s complete set of DNA, comprising all of its genes and it possess entire set of information required to build and maintain organisms. While a digital genome refers to complete digital sets of genetic material that is present in DNA of an organism. It is utilized in the research on genetic disorders and chronic diseases. It offers instant access to trait sequences to understand issues regarding genetics of the diseases. Digital genomics has revolutionized innovation-centered research to derive valuable insights and understand complex genetic mechanisms.

Digital-Genome

Genomics is a traditional concept with traces of genome market traced back right from 1926 when a geneticist at the Jackson Laboratory Tom Roderick, coined the term genomics. In 1981, the 1st complete genome sequence of the human mitochondrion (16.6 kb), was registered. Then in 2003 the accomplishment of the Human Genome Project, sequencing of 3.2 billion base pairs of a DNA that make up the human genome, which took many years and cost hefty amounts of time and capital was completely sequenced, with every single human gene sequences were accessible in the public domain. 

COVID – 19 scenario analysis:  

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to digital genome has been reduced and this segment have to face negligence subsequently causing negative impact on digital genome market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Majority of intractable health challenges, especially cancer can be considered genomic as a disease. With digitization of the genome, healthcare professionals would be able to make a better decision regarding cancer treatment by understanding tumor’s genetic make-up. Digital genome would also aid in precision and customized medicine and development of highly targeted therapies with the potential to be applied across many diseases. These factors would fuel the market growth. The digital genome market is further driven by factors including increment in constantly evolving diseases patterns, high demand for precision medicine and treatment of disorders and diseases utilizing advanced technology fueled by digital genomics and heavy funding to research and development activities in genomics. Subsidizes and friendly policies provided by government and regulatory authorities and encouragement in usage of digital genomics are significant for the growth of digital genomics market.

On the contrary, high capital expenditure required to acquire and utilize digital genomics in research and treatment, lack of awareness and dearth of qualified, skilled staff to handle digitized advanced genomics and poorly developed healthcare infrastructure in developing economies are constrains foreseen to cause hindrances in the digital genome market growth. In addition, digital genome data privacy concerns, challenges regarding personal genomic profiling with regard to understanding of the risk of genetic disease have been deterrents restricting the market growth.  

However, the untapped markets in the Asia Pacific region are evaluated to develop at a significant rate due to rise in geriatric populace, developing infrastructure and insurance administrations would create profitable ventures for digital genome market.

Technological advancements to boost the market growth

Recent technological advancements and growing awareness regarding advantages in use of genomes for detection and treatment of diseases, primarily cancer is expected to drive growth of the digital genome market. For instance, the National Human Genome Research Institute (NHGRI) launched a strategic planning in February 2018, which will establish a plan of action for genomics research focusing on acceleration of breakthroughs and innovations in biomedical field. 

Integration of Artificial Intelligence and machine learning in current healthcare mechanisms are used to resolve issues such as identification of splice sites, promoters, enhancers, and positioned nucleosomes, annotating genomic sequence elements usually faced by genomics. For example, Congenica introduced a clinical genomics analysis platform Sapientia that uses algorithms to annotate and priorities variants from whole-exome sequencing to assist in the diagnosis of rare diseases by understanding their genetic makeup.

In December 2017, Google launched an Artificial Intelligence (AI) tool called DeepVariant, which uses AI to create precise model of an individual genome using sequencing data. From sequencing data, it is capable of automatically identifying mutations in small insertion and deletion, and single base-pair. 

Recently, the Canadian Genomics Cloud launched a public cloud platform that allows researchers from Canada to collect, store, share, and analyze genomics data for further discoveries ensuring privacy and security.  

Rising demand for personalized medications to fuel the growth

As per statistics and research by WHO, cancer is one of the prime causes of morbidity and mortality worldwide, accounting for almost 14 million cases in 2012. WHO also stats that 30-50% of deaths caused due to cancer can be reduced by appropriate treatment in early stages after diagnosis. Personalized medicine offers prominent techniques to fight diseases. Furthermore, rising incidences in diseases like AHDH, cancer require specialised and personalized treatment therapies owing to the nature of disease. With digitization of the genome, healthcare professionals would be able to make a better decision regarding cancer treatment by understanding tumor’s genetic make-up. These factors are promising the development of digital genomics market in near future.

Key benefits of the report:

  • This study presents the analytical depiction of the global digital genome industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global digital genome market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the digital genome treatment market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global digital genome market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Digital genome market research report:

  • What are the leading market players active in the digital genome market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Digital Genome Market Report Highlights

Aspects Details
By Product type
  • Sequencing & analyzer instruments
  • DNA/RNA analysis kits
  • Sequencing & analysis software
  • Sample preparation instruments
By Applications
  • Microbiology
  • Reproductive & Genetic
  • Transplantation and Agriculture
  • Forensics
  • Research and Development
By End users
  • Academic Research Institutes
  • Diagnostics & Forensic Labs
  • Hospitals
  • Bio-pharmaceutical Companies
By Region
  • North America  (US, Canada, Mexico)
  • Europe  (France, Germany, UK, Italy, Spain, rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, rest of Asia-Pacific)
  • LAMEA  (Brazil, South Arabia, South Africa, rest of LAMEA)
Key Market Players Agilent Technologies Inc., bioMerieux, Becton Dickinson and Company, Genomic Health Inc., GenMark Diagnostics Inc., Illumina, Pacific Bioscience, PerkinElmer Inc., Quest Diagnostics Inc., Qiagen and Thermo Fisher Scientific.
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Digital Genome Market

Start reading.
This Report and over 19,260+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers